1、Arsenic Trioxide in Refractory Solid Tumors with Rescuable p53 Mutation (https://www.clinicaltrials.gov/ct2/show/NCT04869475)

2、Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS。(https://www.clinicaltrials.gov/ct2/show/NCT03855371)

3、Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations (https://www.clinicaltrials.gov/ct2/show/NCT04906031)

4、Introduction in TP53 Trust (http://tp53.co.uk/interview-with-min-lu/)

5、Introduction in AntiCancer Fund (https://www.anticancerfund.org/en/blog/latest-news-about-drug-repurposing-oncology-4)